Pharma & Biotech

In a significant advancement for pediatric oncology, Jazz Pharmaceuticals has secured accelerated FDA approval for its novel treatment targeting a...

While Zevra Therapeutics recently announced encouraging clinical results for its lead drug candidate, MIPLYFFA, its stock performance tells a contrasting...

Enanta Pharmaceuticals is navigating a significant leadership transition following the passing of its long-time Chief Financial Officer, Paul J. Mellett...

Lifecore Biomedical finds itself at a crossroads, navigating a complex landscape defined by strategic progress and immediate financial pressures. The...

Lyell Immunopharma has initiated a pivotal Phase 3 clinical trial for its lead CAR T-cell therapy, marking a significant strategic...

The biotechnology sector has found a standout performer in Incyte Corporation. While numerous competitors grapple for incremental growth, this company...

The investment narrative surrounding Denali Therapeutics presents a fascinating paradox. While its pipeline of therapies for neurodegenerative diseases generates significant...

Biopharmaceutical company NuCana faces a period of significant catalysts and challenges. With crucial clinical data on the horizon and a...

While Twist Bioscience delivered exceptional third-quarter financial results, its shares continue to face significant pressure from both legal proceedings and...

Bayer AG faces renewed pressure as a highly anticipated cardiovascular drug candidate failed to meet its primary endpoint in critical...